A cancer drug killed child brain tumor cells in the lab but did not help mice live longer
Original title: Preclinical evaluation of ixazomib for high-risk pediatric brain tumors
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was only tested on cells and mice, and it did not help the mice.
The short version
A drug called ixazomib killed tumor cells in the lab, but it did not help mice with brain tumors live longer.
What was studied. Researchers tested the drug ixazomib on three hard-to-treat child brain tumors. These were DMG, one type of medulloblastoma, and ATRT. They used tumor cells in the lab and mice with these tumors growing in their brains.
What they found. In the lab, even small amounts of the drug killed tumor cells from all three tumor types. But mice treated with the drug did not live longer. Tests showed that too little of the drug seemed to reach the brain, compared to other parts of the body.
What this means, and what it doesn't
What it could mean: These tumors may be weak against this kind of drug. But this drug may not get into the brain well enough to help. Researchers may look for a similar drug that can reach the brain better.
What it doesn't mean: This does not mean ixazomib helps children with brain tumors. It was only tested on cells and mice, not people, and it did not help the mice live longer. This is far from everyday care, and it is not a cure.
Source: bioRxiv (preprint), September 18, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.